Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Clinical trial NCT06782932 · RECRUITING
Trial details
- NCT number
- NCT06782932
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-27
- Primary completion
- 2028-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.